These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 27615504

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Cytotoxic potential of IL-15-activated cytokine-induced killer cells against human neuroblastoma cells.
    Cappel C, Huenecke S, Suemmerer A, Erben S, Rettinger E, Pfirrmann V, Heinze A, Zimmermann O, Klingebiel T, Ullrich E, Bader P, Bremm M.
    Pediatr Blood Cancer; 2016 Dec; 63(12):2230-2239. PubMed ID: 27433920
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the proliferation, cytotoxic activity and cytokine secretion function of cascade primed immune cells and cytokine-induced killer cells in vitro.
    Li GX, Zhao SS, Zhang XG, Wang WH, Liu J, Xue KW, Li XY, Guo YX, Wang LH.
    Mol Med Rep; 2015 Aug; 12(2):2629-35. PubMed ID: 25955083
    [Abstract] [Full Text] [Related]

  • 4. The cytotoxic potential of interleukin-15-stimulated cytokine-induced killer cells against leukemia cells.
    Rettinger E, Kuçi S, Naumann I, Becker P, Kreyenberg H, Anzaghe M, Willasch A, Koehl U, Bug G, Ruthardt M, Klingebiel T, Fulda S, Bader P.
    Cytotherapy; 2012 Jan; 14(1):91-103. PubMed ID: 21973023
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The CIK cells stimulated with combination of IL-2 and IL-15 provide an improved cytotoxic capacity against human lung adenocarcinoma.
    Wei C, Wang W, Pang W, Meng M, Jiang L, Xue S, Xie Y, Li R, Hou Z.
    Tumour Biol; 2014 Mar; 35(3):1997-2007. PubMed ID: 24104501
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cytokine-induced killer cells as immunotherapy for solid tumors: current evidence and perspectives.
    Giraudo L, Gammaitoni L, Cangemi M, Rotolo R, Aglietta M, Sangiolo D.
    Immunotherapy; 2015 Mar; 7(9):999-1010. PubMed ID: 26310715
    [Abstract] [Full Text] [Related]

  • 11. Dual-functional capability of CD3+CD56+ CIK cells, a T-cell subset that acquires NK function and retains TCR-mediated specific cytotoxicity.
    Pievani A, Borleri G, Pende D, Moretta L, Rambaldi A, Golay J, Introna M.
    Blood; 2011 Sep 22; 118(12):3301-10. PubMed ID: 21821703
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. NKG2D Engagement Alone Is Sufficient to Activate Cytokine-Induced Killer Cells While 2B4 Only Provides Limited Coactivation.
    Wu X, Sharma A, Oldenburg J, Weiher H, Essler M, Skowasch D, Schmidt-Wolf IGH.
    Front Immunol; 2021 Sep 22; 12():731767. PubMed ID: 34691037
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. IL-15 improves the cytotoxicity of cytokine-induced killer cells against leukemia cells by upregulating CD3+CD56+ cells and downregulating regulatory T cells as well as IL-35.
    Tao Q, Chen T, Tao L, Wang H, Pan Y, Xiong S, Zhai Z.
    J Immunother; 2013 Sep 22; 36(9):462-7. PubMed ID: 24145357
    [Abstract] [Full Text] [Related]

  • 16. Optimized protocols for generation of cord blood-derived cytokine-induced killer/natural killer cells.
    Li Y, Schmidt-Wolf IG, Wu YF, Huang SL, Wei J, Fang J, Huang K, Zhou DH.
    Anticancer Res; 2010 Sep 22; 30(9):3493-9. PubMed ID: 20944128
    [Abstract] [Full Text] [Related]

  • 17. Thymoglobulin, interferon-γ and interleukin-2 efficiently expand cytokine-induced killer (CIK) cells in clinical-grade cultures.
    Bonanno G, Iudicone P, Mariotti A, Procoli A, Pandolfi A, Fioravanti D, Corallo M, Perillo A, Scambia G, Pierelli L, Rutella S.
    J Transl Med; 2010 Dec 07; 8():129. PubMed ID: 21138560
    [Abstract] [Full Text] [Related]

  • 18. [Thymoglobulin efficiently expands cytokine-induced killer cells in a clinical-grade culture protocol].
    Chen W, Lin D, Jiang Z, Yang Z, Song S, Zhou J, Zhou L, Sun Y, Yu H, Ma D.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jul 07; 30(7):681-5, 690. PubMed ID: 25001928
    [Abstract] [Full Text] [Related]

  • 19. [Effects of humanized interleukin 21 on anti-leukemic activity of cytokine induced killer cells and the mechanism].
    Zhao N, Zhao MF, Rajbhandary S, Lu WY, Zhu HB, Xiao X, Deng Q, Li YM.
    Zhonghua Xue Ye Xue Za Zhi; 2012 Oct 07; 33(10):823-8. PubMed ID: 23384903
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.